{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:50:36Z","timestamp":1791021036385,"version":"4.1.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16dk0307047h0002"],"award-info":[{"award-number":["16dk0307047h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["16dm0107095h0001"],"award-info":[{"award-number":["16dm0107095h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP15K15431"],"award-info":[{"award-number":["JP15K15431"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16H02666"],"award-info":[{"award-number":["JP16H02666"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP16H03741"],"award-info":[{"award-number":["JP16H03741"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP26713039"],"award-info":[{"award-number":["JP26713039"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["JP16H06403"],"award-info":[{"award-number":["JP16H06403"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["JP25117011"],"award-info":[{"award-number":["JP25117011"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jad.2018.01.014","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T09:16:29Z","timestamp":1517476589000},"page":"74-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"special_numbering":"C","title":["Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-na\u00efve patients with major depressive disorder: An exploratory pilot case-control study"],"prefix":"10.1016","volume":"231","author":[{"given":"Nobuki","family":"Kuwano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro A.","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Setoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Sato-Kasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ohgidani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Sagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongchon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigenob","family":"Kanba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2018.01.014_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/mpr.138","article-title":"The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys","volume":"12","author":"Andrade","year":"2003","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.jad.2018.01.014_bib2","doi-asserted-by":"crossref","first-page":"878","DOI":"10.15252\/msb.20156651","article-title":"Deep learning for computational biology","volume":"12","author":"Angermueller","year":"2016","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.jad.2018.01.014_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.bbi.2014.07.012","article-title":"A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality","volume":"43","author":"Bay-Richter","year":"2015","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.jad.2018.01.014_bib4","series-title":"Manual for Beck Depression Inventory-Second Edition","author":"Beck","year":"1996"},{"key":"10.1016\/j.jad.2018.01.014_bib5","doi-asserted-by":"crossref","first-page":"e865","DOI":"10.1038\/tp.2016.133","article-title":"An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation","volume":"6","author":"Brundin","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2018.01.014_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1476-511X-11-116","article-title":"Beneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome","volume":"11","author":"Burillo","year":"2012","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jad.2018.01.014_bib7","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00406-014-0562-0","article-title":"Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses?","volume":"265","author":"Busse","year":"2015","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2018.01.014_bib8","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2011.05.013","article-title":"Biological activities of HDL subpopulations and their relevance to cardiovascular disease","volume":"17","author":"Camont","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jad.2018.01.014_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.bbalip.2016.06.020","article-title":"Oxidized cholesteryl esters and inflammation","volume":"1862","author":"Choi","year":"2017","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jad.2018.01.014_bib10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jrp.2007.09.007","article-title":"The underlying structure of the Beck Depression Inventory II: a multidimensional scaling approach","volume":"42","author":"Cohen","year":"2008","journal-title":"J. Res. Pers."},{"key":"10.1016\/j.jad.2018.01.014_bib11","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1192\/bjp.113.504.1237","article-title":"The biochemistry of affective disorders","volume":"113","author":"Coppen","year":"1967","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.01.014_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/7854_2016_6","article-title":"Role of the Kynurenine metabolism pathway in inflammation-induced depression: preclinical approaches","volume":"31","author":"Dantzer","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.jad.2018.01.014_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jad.2018.01.014_bib14","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.psyneuen.2010.09.012","article-title":"Inflammation-associated depression: from serotonin to kynurenine","volume":"36","author":"Dantzer","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jad.2018.01.014_bib15","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pnpbp.2017.04.027","article-title":"Shared metabolic and immune-inflammatory, oxidative and nitrosative stress pathways in the metabolic syndrome and mood disorders","volume":"78","author":"de Melo","year":"2017","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.01.014_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jad.2017.07.043","article-title":"Prevalence of suicidal behaviors in patients with major depressive disorder in China: a comprehensive meta-analysis","volume":"225","author":"Dong","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.01.014_bib17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0896-6273(00)00112-4","article-title":"Major depressive disorder","volume":"28","author":"Fava","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.jad.2018.01.014_bib18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0026-0495(77)90057-9","article-title":"Effects on the diet on brain neurotransmitters","volume":"26","author":"Fernstrom","year":"1977","journal-title":"Metabolism"},{"key":"10.1016\/j.jad.2018.01.014_bib19","series-title":"Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I\/P)","author":"First","year":"2002"},{"key":"10.1016\/j.jad.2018.01.014_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1155\/2006\/202938","article-title":"Identification of disease markers in human cerebrospinal fluid using lipidomic and proteomic methods","volume":"22","author":"Fonteh","year":"2006","journal-title":"Dis. Markers"},{"key":"10.1016\/j.jad.2018.01.014_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0003-9861(86)90526-6","article-title":"Biological effects of the superoxide radical","volume":"247","author":"Fridovich","year":"1986","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jad.2018.01.014_bib22","article-title":"Peripheral biomarkers of major depression and antidepressant treatment response: current knowledge and future outlooks","author":"Gadad","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.01.014_bib23","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jad.2015.01.014","article-title":"Duration of untreated depression influences clinical outcomes and disability","volume":"175","author":"Ghio","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.01.014_bib24","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2018.01.014_bib25","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.4088\/JCP.14m09391","article-title":"The predictive validity of the beck depression inventory suicide item","volume":"76","author":"Green","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.01.014_bib26","doi-asserted-by":"crossref","first-page":"e96905","DOI":"10.1371\/journal.pone.0096905","article-title":"Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials","volume":"9","author":"Grosso","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2018.01.014_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neubiorev.2016.02.011","article-title":"Molecular biomarkers of depression","volume":"64","author":"Gururajan","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2018.01.014_bib28","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","article-title":"Cumulative meta-analysis of interleukins 6 and 1beta, tumour necrosis factor alpha and C-reactive protein in patients with major depressive disorder","volume":"49","author":"Haapakoski","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2018.01.014_bib29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/s11920-013-0400-5","article-title":"Inflammation, heart disease, and depression","volume":"15","author":"Halaris","year":"2013","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2018.01.014_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/7854_2016_28","article-title":"Inflammation-associated co-morbidity between depression and cardiovascular disease","volume":"31","author":"Halaris","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.jad.2018.01.014_bib31","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jpsychires.2015.04.026","article-title":"Does escitalopram reduce neurotoxicity in major depression?","volume":"66\u201367","author":"Halaris","year":"2015","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2018.01.014_bib32","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","article-title":"Oxidative stress and neurodegeneration: where are we now?","volume":"97","author":"Halliwell","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jad.2018.01.014_bib33","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jagp.2013.11.003","article-title":"Minocycline, a microglial inhibitor, diminishes terminal patients' delirium?","volume":"22","author":"Hayakawa","year":"2014","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jad.2018.01.014_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.arcmed.2006.10.005","article-title":"Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment","volume":"38","author":"Herken","year":"2007","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.jad.2018.01.014_bib35","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1073\/pnas.77.12.7463","article-title":"Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes","volume":"77","author":"Heron","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jad.2018.01.014_bib36","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.pnpbp.2010.07.015","article-title":"Inhibitory effects of SSRIs on IFN-gamma induced microglial activation through the regulation of intracellular calcium","volume":"34","author":"Horikawa","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.01.014_bib37","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jad.2018.01.014_bib38","article-title":"Deficit, but not Nondeficit, schizophrenia is characterized by mucosa-associated activation of the tryptophan catabolite (TRYCAT) Pathway with highly specific increases in IgA responses directed to picolinic, xanthurenic, and quinolinic acid","author":"Kanchanatawan","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jad.2018.01.014_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/pcn.12360","article-title":"Multidimensional anatomy of 'modern type depression' in Japan: a proposal for a different diagnostic approach to depression beyond the DSM-5","volume":"70","author":"Kato","year":"2016","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2018.01.014_bib40","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1176\/appi.ajp.2017.17010059","article-title":"Modern-Type Depression as an \"Adjustment\" Disorder in Japan: the Intersection of Collectivistic Society Encountering an Individualistic Performance-Based System","volume":"174","author":"Kato","year":"2017","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2018.01.014_bib41","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2174\/138955711795906941","article-title":"Anti-Inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia?","volume":"11","author":"Kato","year":"2011","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.jad.2018.01.014_bib42","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jad.2011.06.030","article-title":"Introducing the concept of modern depression in Japan; an international case vignette survey","volume":"135","author":"Kato","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.01.014_bib43","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0140-6736(11)61475-X","article-title":"Are Japan's hikikomori and depression in young people spreading abroad?","volume":"378","author":"Kato","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2018.01.014_bib44","first-page":"331","article-title":"Neurotransmitters, psychotropic drugs and microglia: clinical implications for psychiatry","volume":"20","author":"Kato","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jad.2018.01.014_bib45","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/pcn.12299","article-title":"Biochemical markers subtyping major depressive disorder","volume":"69","author":"Kunugi","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2018.01.014_bib46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neubiorev.2016.07.002","article-title":"Social functioning in major depressive disorder","volume":"69","author":"Kupferberg","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2018.01.014_bib47","doi-asserted-by":"crossref","first-page":"e0138904","DOI":"10.1371\/journal.pone.0138904","article-title":"A meta-analysis of oxidative stress markers in depression","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2018.01.014_bib48","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1021\/acs.jproteome.5b00144","article-title":"Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry","volume":"14","author":"Liu","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.jad.2018.01.014_bib49","doi-asserted-by":"crossref","first-page":"6497","DOI":"10.1007\/s00216-016-9768-5","article-title":"Plasma lipidomics reveals potential lipid markers of major depressive disorder","volume":"408","author":"Liu","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jad.2018.01.014_bib50","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1089\/met.2017.0008","article-title":"Atherogenic Indices Are Increased In Elderly Patients With Unipolar Depression-case-control Analysis","volume":"15","author":"Lucka","year":"2017","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.jad.2018.01.014_bib51","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.ntt.2011.07.002","article-title":"On the antioxidant properties of kynurenic acid: free radical scavenging activity and inhibition of oxidative stress","volume":"33","author":"Lugo-Huitron","year":"2011","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.jad.2018.01.014_bib52","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1741-7015-10-66","article-title":"Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways","volume":"10","author":"Maes","year":"2012","journal-title":"BMC Med."},{"key":"10.1016\/j.jad.2018.01.014_bib53","first-page":"120","article-title":"Xanthurenic acid flow in 24-hour urine following L-tryptophan loading in depressive patients","volume":"86","author":"Maes","year":"1986","journal-title":"Acta Psychiatr. Belg."},{"key":"10.1016\/j.jad.2018.01.014_bib54","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0447.1994.tb01589.x","article-title":"Lower degree of esterification of serum cholesterol in depression: relevance for depression and suicide research","volume":"90","author":"Maes","year":"1994","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2018.01.014_bib55","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.pnpbp.2010.05.004","article-title":"A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.01.014_bib56","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.pnpbp.2010.12.017","volume":"35","author":"Maes","year":"2011","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2018.01.014_bib57","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jad.2009.12.014","article-title":"Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease","volume":"125","author":"Maes","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.01.014_bib58","first-page":"826","article-title":"The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation","volume":"28","author":"Maes","year":"2007","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.jad.2018.01.014_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","article-title":"The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression","volume":"24","author":"Maes","year":"2009","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.jad.2018.01.014_bib60","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1001\/jama.294.16.2064","article-title":"Suicide prevention strategies: a systematic review","volume":"294","author":"Mann","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2018.01.014_bib61","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1017\/S1092852915000449","article-title":"Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways","volume":"21","author":"Martin-Subero","year":"2016","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2018.01.014_bib62","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.2174\/138161212803523554","article-title":"The role of oxidative stress in depressive disorders","volume":"18","author":"Michel","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jad.2018.01.014_bib63","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(09)60879-5","article-title":"Clinical diagnosis of depression in primary care: a meta-analysis","volume":"374","author":"Mitchell","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2018.01.014_bib64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1440-1819.2009.01945.x","article-title":"Cytokines and schizophrenia: microglia hypothesis of schizophrenia","volume":"63","author":"Monji","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jad.2018.01.014_bib65","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/bmj.301.6747.309","article-title":"Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials","volume":"301","author":"Muldoon","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.jad.2018.01.014_bib66","doi-asserted-by":"crossref","first-page":"391984","DOI":"10.1155\/2013\/391984","article-title":"Remarkable role of indoleamine 2,3-dioxygenase and tryptophan metabolites in infectious diseases: potential role in macrophage-mediated inflammatory diseases","volume":"2013","author":"Murakami","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jad.2018.01.014_bib67","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1742-4658.2012.08551.x","article-title":"Kynurenines: from the perspective of major psychiatric disorders","volume":"279","author":"Myint","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.jad.2018.01.014_bib68","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","article-title":"Kynurenine pathway in major depression: evidence of impaired neuroprotection","volume":"98","author":"Myint","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2018.01.014_bib69","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00702-011-0741-3","article-title":"The role of the kynurenine metabolism in major depression","volume":"119","author":"Myint","year":"2012","journal-title":"J. Neural Transm. (Vienna)"},{"key":"10.1016\/j.jad.2018.01.014_bib70","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1742-2094-10-142","article-title":"Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence","volume":"10","author":"Najjar","year":"2013","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.jad.2018.01.014_bib71","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1567202054368326","article-title":"Role of kynurenines in the central and peripheral nervous systems","volume":"2","author":"Nemeth","year":"2005","journal-title":"Curr. Neurovasc. Res."},{"key":"10.1016\/j.jad.2018.01.014_bib72","doi-asserted-by":"crossref","first-page":"e906","DOI":"10.4088\/JCP.13r08908","article-title":"Plasma L-tryptophan concentration in major depressive disorder: new data and meta-analysis","volume":"75","author":"Ogawa","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2018.01.014_bib73","first-page":"676","article-title":"Microglial CD206 gene has potential as a state marker of bipolar disorder","volume":"7","author":"Ohgidani","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jad.2018.01.014_bib74","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.euroneuro.2016.05.005","article-title":"Increased plasma levels of competing amino acids, rather than lowered plasma tryptophan levels, are associated with a non-response to treatment in major depression","volume":"26","author":"Ormstad","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2018.01.014_bib75","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2174\/1389450111314050002","article-title":"Serotonin-kynurenine hypothesis of depression: historical overview and recent developments","volume":"14","author":"Oxenkrug","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.jad.2018.01.014_bib76","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3390\/healthcare5010005","article-title":"The role of lipid biomarkers in major depression","author":"Parekh","year":"2017","journal-title":"Healthcare"},{"key":"10.1016\/j.jad.2018.01.014_bib77","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1600-0447.2011.01706.x","article-title":"Mood effects of the amino acids tryptophan and tyrosine: 'food for Thought' III","volume":"124","author":"Parker","year":"2011","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2018.01.014_bib78","doi-asserted-by":"crossref","first-page":"34402","DOI":"10.1038\/srep34402","article-title":"The significance of routine biochemical markers in patients with major depressive disorder","volume":"6","author":"Peng","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jad.2018.01.014_bib79","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0893-133X(97)00084-5","article-title":"Neurobiology of tryptophan depletion in depression: effects of m-chlorophenylpiperazine (mCPP)","volume":"17","author":"Price","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2018.01.014_bib80","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s11011-017-0040-2","volume":"32","author":"Roomruangwong","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.jad.2018.01.014_bib81","first-page":"19","article-title":"The cognitive effects of Antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials","author":"Rosenblat","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2018.01.014_bib82","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.schres.2016.08.022","article-title":"Aripiprazole inhibits polyI: c-induced microglial activation possibly via TRPM7","volume":"178","author":"Sato-Kasai","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2018.01.014_bib83","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2005.06.013","article-title":"Monitoring tryptophan metabolism in chronic immune activation","volume":"364","author":"Schrocksnadel","year":"2006","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jad.2018.01.014_bib84","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.jad.2018.01.014_bib85","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","article-title":"The kynurenine pathway and the brain: challenges, controversies and promises","volume":"112","author":"Schwarcz","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2018.01.014_bib86","doi-asserted-by":"crossref","first-page":"e0165267","DOI":"10.1371\/journal.pone.0165267","article-title":"Plasma metabolites predict severity of depression and suicidal ideation in psychiatric patients-a multicenter pilot analysis","volume":"11","author":"Setoyama","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jad.2018.01.014_bib87","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.pneurobio.2010.04.004","article-title":"Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression","volume":"91","author":"Shelton","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.jad.2018.01.014_bib88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12160-008-9045-8","article-title":"Are cholesterol and depression inversely related? A meta-analysis of the association between two cardiac risk factors","volume":"36","author":"Shin","year":"2008","journal-title":"Ann. Behav. Med."},{"key":"10.1016\/j.jad.2018.01.014_bib89","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/515180a","article-title":"Mental health: a world of depression","volume":"515","author":"Smith","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jad.2018.01.014_bib90","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/CIRCRESAHA.115.306246","article-title":"Microdomains, inflammation, and atherosclerosis","volume":"118","author":"Sorci-Thomas","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.jad.2018.01.014_bib91","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1742-2094-8-94","article-title":"Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?","volume":"8","author":"Steiner","year":"2011","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.jad.2018.01.014_bib92","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bbi.2011.05.002","article-title":"Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder","volume":"25","author":"Sublette","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2018.01.014_bib93","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cccn.2005.04.003","article-title":"Cholesteryl esters in malignancy","volume":"359","author":"Tosi","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jad.2018.01.014_bib94","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1007\/s00216-015-9256-3","article-title":"Lipidomic profiling of tryptophan hydroxylase 2 knockout mice reveals novel lipid biomarkers associated with serotonin deficiency","volume":"408","author":"Weng","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jad.2018.01.014_bib95","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1503\/jpn.150079","article-title":"Serum lipid levels and suicidality: a meta-analysis of 65 epidemiological studies","volume":"41","author":"Wu","year":"2016","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jad.2018.01.014_bib96","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.psychres.2012.05.027","article-title":"Potential clinical utility of plasma amino acid profiling in the detection of major depressive disorder","volume":"200","author":"Xu","year":"2012","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2018.01.014_bib97","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archgenpsychiatry.2011.1493","article-title":"Positron emission tomography study of the effects of tryptophan depletion on brain serotonin(2) receptors in subjects recently remitted from major depression","volume":"69","author":"Yatham","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2018.01.014_bib98","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1503\/jpn.120209","article-title":"Acute tryptophan depletion in humans: a review of theoretical, practical and ethical aspects","volume":"38","author":"Young","year":"2013","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jad.2018.01.014_bib99","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF00431803","article-title":"Tryptophan depletion causes a rapid lowering of mood in normal males","volume":"87","author":"Young","year":"1985","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.jad.2018.01.014_bib100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.numecd.2014.11.004","article-title":"Impact of cholesterol lowering treatment on plasma kynurenine and tryptophan concentrations in chronic kidney disease: relationship with oxidative stress improvement","volume":"25","author":"Zinellu","year":"2015","journal-title":"Nutr. Metab. Cardiovasc. Dis."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717316609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717316609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T04:51:14Z","timestamp":1655614274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032717316609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":100,"alternative-id":["S0165032717316609"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2018.01.014","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-na\u00efve patients with major depressive disorder: An exploratory pilot case-control study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2018.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}